blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3824948

EP3824948 - A PLANNING AND/OR CONTROL SYSTEM FOR A NEUROMODULATION SYSTEM [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  02.03.2023
Database last updated on 25.09.2024
FormerRequest for examination was made
Status updated on  03.12.2021
FormerThe application has been published
Status updated on  23.04.2021
Most recent event   Tooltip24.11.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
ONWARD Medical N.V.
Schimmelt 2-16
5611 ZX Eindhoven / NL
[2023/11]
Former [2022/11]For all designated states
ONWARD Medical N.V.
High Tech Campus 32
5656 AE Eindhoven / NL
Former [2021/21]For all designated states
ONWARD Medical B.V.
High Tech Campus 32
5656 AE Eindhoven / NL
Inventor(s)01 / BROUNS, Robin
c/o GTX medical B.V.
High Tech Campus 32
5656 AE Eindhoven / NL
02 / BAKKER, Jurriaan
c/o GTX medical B.V.
High Tech Campus 32
5656 AE Eindhoven / NL
03 / CABAN, Miroslav
Rue de Crissier 1
1020 Renens / CH
 [2021/21]
Representative(s)DTS Patent- und Rechtsanwälte PartmbB
Brienner Straße 1
80333 München / DE
[N/P]
Former [2021/21]DTS Patent- und Rechtsanwälte Schnekenbühl und Partner mbB
Marstallstrasse 8
80539 München / DE
Application number, filing date19209911.719.11.2019
[2021/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3824948
Date:26.05.2021
Language:EN
[2021/21]
Search report(s)(Supplementary) European search report - dispatched on:EP11.05.2020
ClassificationIPC:A61N1/36, A61N1/372, G16H20/30, G16H40/63
[2021/21]
CPC:
A61N1/3606 (EP); G06F3/04847 (US); A61N1/0551 (US);
A61N1/36062 (EP,US); A61N1/36125 (US); A61N1/36128 (US);
A61N1/36157 (EP); A61N1/36182 (EP); A61N1/36185 (US);
A61N1/36189 (US); A61N1/37247 (EP,US); A61N1/37282 (US);
G06F3/0482 (US); G16H20/30 (EP,US); G16H40/63 (EP,US);
A61N1/36003 (EP); G06F3/0488 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/01]
Former [2021/21]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:PLANUNGS- UND/ODER STEUERSYSTEM FÜR EIN NEUROMODULATIONSSYSTEM[2021/21]
English:A PLANNING AND/OR CONTROL SYSTEM FOR A NEUROMODULATION SYSTEM[2021/21]
French:SYSTÈME DE PLANIFICATION ET/OU DE COMMANDE POUR UN SYSTÈME DE NEUROMODULATION[2021/21]
Examination procedure21.10.2021Amendment by applicant (claims and/or description)
26.11.2021Examination requested  [2022/01]
26.11.2021Date on which the examining division has become responsible
01.03.2023Despatch of a communication from the examining division (Time limit: M04)
02.06.2023Reply to a communication from the examining division
20.07.2023Despatch of a communication from the examining division (Time limit: M04)
20.11.2023Reply to a communication from the examining division
Fees paidRenewal fee
30.11.2021Renewal fee patent year 03
18.11.2022Renewal fee patent year 04
23.11.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2012041518  (KIM CHESTER [US], et al) [X] 1-19 * paragraphs [0060] - [0075]; figures 7-10B *;
 [X]US2018056078  (KASHYAP DHEERENDRA RAGHAVENDRA [US], et al) [X] 1-19 * paragraphs [0125] - [0150]; figures 18A-21; claim 1 *;
 [X]WO2018039296  (BOSTON SCIENT NEUROMODULATION CORP [US]) [X] 1-19 * paragraphs [0109] , [0143] - [0144]; figures 17,28-30; claims 1-13 *;
 [X]US2018085583  (ZHANG TIANHE [US], et al) [X] 1-19 * paragraphs [0137] - [0150]; figures 21-23B *;
 [X]US2018193655  (ZHANG TIANHE [US], et al) [X] 1-19 * paragraphs [0080] - [0087]; claims 7-8 *;
 [A]US2019160294  (PETERSON ERIK J [US], et al) [A] 1-19* figures 3-4 *
by applicantUS2012006793
 US8108051
 US2013096662
 EP3013411
 EP3285855
 EP3527258
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.